Tags › factor Xa inhibitors
March 24, 2014

Selections from Richard Lehman’s Literature Review: March 24th
December 5, 2013

Large Study Finds Favorable Risk-Benefit Profile for the New Anticoagulants
September 18, 2013

Is Edoxaban the Most Promising of the Novel Anticoagulants?
November 13, 2011

ATLAS ACS 2-TIMI 51: Rivaroxaban Benefits Low-Risk ACS Patients
July 24, 2011

APPRAISE-2 Dashes Hope of Adding Anticoagulant to Antiplatelet Therapy in ACS
Load more tagged like this…
Back to top
mobile desktop